Pharmacists should brace for yet another medicine shortage. However, this one might actually be beneficial for patients.

With pharmacist prescribing, aged care and scope of practice the top topics of the conference, a record 1,065 pharmacists converged on the Hyatt Regency in Sydney for PSA’s annual conference. There were 3 days of clinical and practice updates, networking...

Creating a tailored, individualised approach is the key to helping patients safely deprescribe from opioids.

This National Pain Week (25 July– 1 August) Australian Pharmacist explores how to help patients cope with chronic pain.

As new pharmacist prescribing pilots and models continue to be introduced, here's a look at the history of prescribing and where it’s headed.

The Medical Services Advisory Committee's support for funding embedded pharmacists in Aboriginal Health Services could be a game changer.

All pharmacists can soon dispense MS-2 Step, following a landmark decision by the Therapeutic Goods Administration.

Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.

All the new initiatives, funding schemes and Pharmaceutical Benefits Scheme (PBS) listings that kicked into gear on 1 July 2023.

The new Opioid Dependence Treatment Program kicks off on 1 July. Here's the steps you need to take before, during and after the transition.